COPD Diagnosis and Individualized Selection of Treatments and Devices: A Path to Better Outcomes

Wednesday, September 25, 2019
6:00 am to 8:00 am
Philadelphia Marriott Downtown
1201 Market Street
Philadelphia, PA 19107
Room: Liberty Ballroom

Sandra G. Adams, MD, MS (Chair)
Professor of Medicine
Division of Pulmonary Diseases and Critical Care Medicine
University of Texas Health San Antonio
South Texas Veterans Health Care System
San Antonio, TX
President/CEO/Board Member
WipeDiseases™ Foundation
Ramon G. Reyes, MD
Diplomate American Board of Family Practice
Family Practice Specialist
Bandera Family Medical Group
San Antonio, TX
Steering Committee
Brian W. Carlin, MD
Sleep Medicine and Lung Health Consultants
Pittsburgh Critical Care Associates
Pittsburgh, PA

This event is not a part of the official AAFP FMX.
This activity is jointly provided by Paradigm Medical Communications, LLC and WipeDiseases™ Foundation. 

Program Description
The nonspecific symptoms and heterogeneous presentations of COPD make this common condition notoriously difficult to diagnose and treat. Yet without recognition and proper therapy, patients are susceptible to preventable COPD-related exacerbations, hospitalizations, and death. Using a novel, interactive, video-enhanced, case-based approach, this expert-led live symposium will familiarize FPs with practical, guideline-recommended tools they can use to confidently make a diagnosis of COPD and to select an individualized treatment plan that fosters adherence and meets patients’ needs.
Target Audience
This activity has been designed to address the educational needs of family physicians (FPs). It may also benefit other healthcare professionals (HCPs) engaged or interested in the care of patients with COPD, including internists, pulmonologists, nurse practitioners (NPs), and PAs.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
•Accurately diagnose patients with COPD based on a thorough evaluation using tests and tools as outlined by current best practice guideline recommendations
•Formulate evidence-based treatment plans for patients with COPD based on symptom severity and exacerbation risk
•Match patients to an appropriate device from among the inhalers and nebulizers available for COPD treatment based on their individual characteristics, including technique needed for proper actuation and use
6:00 am – 6:30 am            Registration and Complimentary Buffet Breakfast
6:30 am – 8:00 am            Clinical Program
•Branched-Logic Video Case Studies: David, Gladys, Donald, and John

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Paradigm Medical Communications, LLC and WipeDiseases™ Foundation. Paradigm Medical Communications, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. 
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
AAFP Credit
This Live activity, COPD Diagnosis and Individualized Selection of Treatments and Devices: A Path to Better Outcomes, with a beginning date of 09/25/2019, has been reviewed and is acceptable for up to 1.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support

This program is supported in part by independent education grants from AstraZeneca Pharmaceuticals LP; Mylan Specialty L.P. and Theravance Biopharma US, Inc; and Sunovion Pharmaceuticals Inc.
Disclosure of Conflicts of Interest
In accordance with ACCME requirements on disclosure, information about relationships with commercial interests (if any) for anyone contributing to content development will be included in materials distributed at the time of the activity.

To register for this complimentary symposium, please click Continue below or call toll-free: (877) 252-5100, ext. 1